The global market for Circadian Rhythm Sleep Disorders Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Circadian Rhythm Sleep Disorders Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circadian Rhythm Sleep Disorders Drug.

The Circadian Rhythm Sleep Disorders Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circadian Rhythm Sleep Disorders Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Circadian Rhythm Sleep Disorders Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Circadian Rhythm Sleep Disorders Drug Market Report

Report Metric	Details
Report Name	Circadian Rhythm Sleep Disorders Drug Market
CAGR	5%
Segment by Type	Melatonin Ramelteon Others
Segment by Application	Delayed Sleep Phase Syndrome (DSPS) Advanced Sleep Phase Syndrome (ASPS) Irregular Sleep-Wake Disorder (ISWD) Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva Pharmaceuticals, Takeda Pharmaceutical, NBTY, Vicks (Procter & Gamble), Natrol, Nature Made (Pharmavite), Jameison, GNC, By-Health, Now Foods, Vitafusion (Church & Dwight), OLLY (Unilever), Doctor's Best (Kingdomway)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circadian Rhythm Sleep Disorders Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Circadian Rhythm Sleep Disorders Drug Market report?

Ans: The main players in the Circadian Rhythm Sleep Disorders Drug Market are Teva Pharmaceuticals, Takeda Pharmaceutical, NBTY, Vicks (Procter & Gamble), Natrol, Nature Made (Pharmavite), Jameison, GNC, By-Health, Now Foods, Vitafusion (Church & Dwight), OLLY (Unilever), Doctor's Best (Kingdomway)

What are the Application segmentation covered in the Circadian Rhythm Sleep Disorders Drug Market report?

Ans: The Applications covered in the Circadian Rhythm Sleep Disorders Drug Market report are Delayed Sleep Phase Syndrome (DSPS), Advanced Sleep Phase Syndrome (ASPS), Irregular Sleep-Wake Disorder (ISWD), Others

What are the Type segmentation covered in the Circadian Rhythm Sleep Disorders Drug Market report?

Ans: The Types covered in the Circadian Rhythm Sleep Disorders Drug Market report are Melatonin, Ramelteon, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Melatonin

1.2.3 Ramelteon

1.2.4 Others

1.3 Market by Application

1.3.1 Global Circadian Rhythm Sleep Disorders Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Delayed Sleep Phase Syndrome (DSPS)

1.3.3 Advanced Sleep Phase Syndrome (ASPS)

1.3.4 Irregular Sleep-Wake Disorder (ISWD)

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Circadian Rhythm Sleep Disorders Drug Market Perspective (2020-2031)

2.2 Global Circadian Rhythm Sleep Disorders Drug Growth Trends by Region

2.2.1 Global Circadian Rhythm Sleep Disorders Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Circadian Rhythm Sleep Disorders Drug Historic Market Size by Region (2020-2025)

2.2.3 Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Region (2026-2031)

2.3 Circadian Rhythm Sleep Disorders Drug Market Dynamics

2.3.1 Circadian Rhythm Sleep Disorders Drug Industry Trends

2.3.2 Circadian Rhythm Sleep Disorders Drug Market Drivers

2.3.3 Circadian Rhythm Sleep Disorders Drug Market Challenges

2.3.4 Circadian Rhythm Sleep Disorders Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Circadian Rhythm Sleep Disorders Drug Players by Revenue

3.1.1 Global Top Circadian Rhythm Sleep Disorders Drug Players by Revenue (2020-2025)

3.1.2 Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Players (2020-2025)

3.2 Global Circadian Rhythm Sleep Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Circadian Rhythm Sleep Disorders Drug Revenue

3.4 Global Circadian Rhythm Sleep Disorders Drug Market Concentration Ratio

3.4.1 Global Circadian Rhythm Sleep Disorders Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Circadian Rhythm Sleep Disorders Drug Revenue in 2024

3.5 Global Key Players of Circadian Rhythm Sleep Disorders Drug Head office and Area Served

3.6 Global Key Players of Circadian Rhythm Sleep Disorders Drug, Product and Application

3.7 Global Key Players of Circadian Rhythm Sleep Disorders Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Circadian Rhythm Sleep Disorders Drug Breakdown Data by Type

4.1 Global Circadian Rhythm Sleep Disorders Drug Historic Market Size by Type (2020-2025)

4.2 Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Type (2026-2031)

5 Circadian Rhythm Sleep Disorders Drug Breakdown Data by Application

5.1 Global Circadian Rhythm Sleep Disorders Drug Historic Market Size by Application (2020-2025)

5.2 Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)

6.2 North America Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)

6.4 North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)

7.2 Europe Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)

7.4 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)

8.2 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)

9.2 Latin America Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)

9.4 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)

10.2 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Teva Pharmaceuticals

11.1.1 Teva Pharmaceuticals Company Details

11.1.2 Teva Pharmaceuticals Business Overview

11.1.3 Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Introduction

11.1.4 Teva Pharmaceuticals Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

11.1.5 Teva Pharmaceuticals Recent Development

11.2 Takeda Pharmaceutical

11.2.1 Takeda Pharmaceutical Company Details

11.2.2 Takeda Pharmaceutical Business Overview

11.2.3 Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Introduction

11.2.4 Takeda Pharmaceutical Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

11.2.5 Takeda Pharmaceutical Recent Development

11.3 NBTY

11.3.1 NBTY Company Details

11.3.2 NBTY Business Overview

11.3.3 NBTY Circadian Rhythm Sleep Disorders Drug Introduction

11.3.4 NBTY Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

11.3.5 NBTY Recent Development

11.4 Vicks (Procter & Gamble)

11.4.1 Vicks (Procter & Gamble) Company Details

11.4.2 Vicks (Procter & Gamble) Business Overview

11.4.3 Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Introduction

11.4.4 Vicks (Procter & Gamble) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

11.4.5 Vicks (Procter & Gamble) Recent Development

11.5 Natrol

11.5.1 Natrol Company Details

11.5.2 Natrol Business Overview

11.5.3 Natrol Circadian Rhythm Sleep Disorders Drug Introduction

11.5.4 Natrol Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

11.5.5 Natrol Recent Development

11.6 Nature Made (Pharmavite)

11.6.1 Nature Made (Pharmavite) Company Details

11.6.2 Nature Made (Pharmavite) Business Overview

11.6.3 Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Introduction

11.6.4 Nature Made (Pharmavite) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

11.6.5 Nature Made (Pharmavite) Recent Development

11.7 Jameison

11.7.1 Jameison Company Details

11.7.2 Jameison Business Overview

11.7.3 Jameison Circadian Rhythm Sleep Disorders Drug Introduction

11.7.4 Jameison Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

11.7.5 Jameison Recent Development

11.8 GNC

11.8.1 GNC Company Details

11.8.2 GNC Business Overview

11.8.3 GNC Circadian Rhythm Sleep Disorders Drug Introduction

11.8.4 GNC Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

11.8.5 GNC Recent Development

11.9 By-Health

11.9.1 By-Health Company Details

11.9.2 By-Health Business Overview

11.9.3 By-Health Circadian Rhythm Sleep Disorders Drug Introduction

11.9.4 By-Health Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

11.9.5 By-Health Recent Development

11.10 Now Foods

11.10.1 Now Foods Company Details

11.10.2 Now Foods Business Overview

11.10.3 Now Foods Circadian Rhythm Sleep Disorders Drug Introduction

11.10.4 Now Foods Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

11.10.5 Now Foods Recent Development

11.11 Vitafusion (Church & Dwight)

11.11.1 Vitafusion (Church & Dwight) Company Details

11.11.2 Vitafusion (Church & Dwight) Business Overview

11.11.3 Vitafusion (Church & Dwight) Circadian Rhythm Sleep Disorders Drug Introduction

11.11.4 Vitafusion (Church & Dwight) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

11.11.5 Vitafusion (Church & Dwight) Recent Development

11.12 OLLY (Unilever)

11.12.1 OLLY (Unilever) Company Details

11.12.2 OLLY (Unilever) Business Overview

11.12.3 OLLY (Unilever) Circadian Rhythm Sleep Disorders Drug Introduction

11.12.4 OLLY (Unilever) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

11.12.5 OLLY (Unilever) Recent Development

11.13 Doctor's Best (Kingdomway)

11.13.1 Doctor's Best (Kingdomway) Company Details

11.13.2 Doctor's Best (Kingdomway) Business Overview

11.13.3 Doctor's Best (Kingdomway) Circadian Rhythm Sleep Disorders Drug Introduction

11.13.4 Doctor's Best (Kingdomway) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

11.13.5 Doctor's Best (Kingdomway) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Teva Pharmaceuticals

Takeda Pharmaceutical

NBTY

Vicks (Procter & Gamble)

Natrol

Nature Made (Pharmavite)

Vitafusion (Church & Dwight)

Olly(Unilever)

Doctor's Best (Kingdomway)

List of Tables

Table 1. Global Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Melatonin

Table 3. Key Players of Ramelteon

Table 4. Key Players of Others

Table 5. Global Circadian Rhythm Sleep Disorders Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Circadian Rhythm Sleep Disorders Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Circadian Rhythm Sleep Disorders Drug Market Share by Region (2020-2025)

Table 9. Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Circadian Rhythm Sleep Disorders Drug Market Share by Region (2026-2031)

Table 11. Circadian Rhythm Sleep Disorders Drug Market Trends

Table 12. Circadian Rhythm Sleep Disorders Drug Market Drivers

Table 13. Circadian Rhythm Sleep Disorders Drug Market Challenges

Table 14. Circadian Rhythm Sleep Disorders Drug Market Restraints

Table 15. Global Circadian Rhythm Sleep Disorders Drug Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Circadian Rhythm Sleep Disorders Drug Market Share by Players (2020-2025)

Table 17. Global Top Circadian Rhythm Sleep Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circadian Rhythm Sleep Disorders Drug as of 2024)

Table 18. Ranking of Global Top Circadian Rhythm Sleep Disorders Drug Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Circadian Rhythm Sleep Disorders Drug Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Circadian Rhythm Sleep Disorders Drug, Headquarters and Area Served

Table 21. Global Key Players of Circadian Rhythm Sleep Disorders Drug, Product and Application

Table 22. Global Key Players of Circadian Rhythm Sleep Disorders Drug, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Circadian Rhythm Sleep Disorders Drug Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Type (2020-2025)

Table 26. Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Type (2026-2031)

Table 28. Global Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Application (2020-2025)

Table 30. Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Application (2026-2031)

Table 32. North America Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031) & (US$ Million)

Table 47. Teva Pharmaceuticals Company Details

Table 48. Teva Pharmaceuticals Business Overview

Table 49. Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Product

Table 50. Teva Pharmaceuticals Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)

Table 51. Teva Pharmaceuticals Recent Development

Table 52. Takeda Pharmaceutical Company Details

Table 53. Takeda Pharmaceutical Business Overview

Table 54. Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Product

Table 55. Takeda Pharmaceutical Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)

Table 56. Takeda Pharmaceutical Recent Development

Table 57. NBTY Company Details

Table 58. NBTY Business Overview

Table 59. NBTY Circadian Rhythm Sleep Disorders Drug Product

Table 60. NBTY Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)

Table 61. NBTY Recent Development

Table 62. Vicks (Procter & Gamble) Company Details

Table 63. Vicks (Procter & Gamble) Business Overview

Table 64. Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Product

Table 65. Vicks (Procter & Gamble) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)

Table 66. Vicks (Procter & Gamble) Recent Development

Table 67. Natrol Company Details

Table 68. Natrol Business Overview

Table 69. Natrol Circadian Rhythm Sleep Disorders Drug Product

Table 70. Natrol Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)

Table 71. Natrol Recent Development

Table 72. Nature Made (Pharmavite) Company Details

Table 73. Nature Made (Pharmavite) Business Overview

Table 74. Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Product

Table 75. Nature Made (Pharmavite) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)

Table 76. Nature Made (Pharmavite) Recent Development

Table 77. Jameison Company Details

Table 78. Jameison Business Overview

Table 79. Jameison Circadian Rhythm Sleep Disorders Drug Product

Table 80. Jameison Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)

Table 81. Jameison Recent Development

Table 82. GNC Company Details

Table 83. GNC Business Overview

Table 84. GNC Circadian Rhythm Sleep Disorders Drug Product

Table 85. GNC Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)

Table 86. GNC Recent Development

Table 87. By-Health Company Details

Table 88. By-Health Business Overview

Table 89. By-Health Circadian Rhythm Sleep Disorders Drug Product

Table 90. By-Health Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)

Table 91. By-Health Recent Development

Table 92. Now Foods Company Details

Table 93. Now Foods Business Overview

Table 94. Now Foods Circadian Rhythm Sleep Disorders Drug Product

Table 95. Now Foods Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)

Table 96. Now Foods Recent Development

Table 97. Vitafusion (Church & Dwight) Company Details

Table 98. Vitafusion (Church & Dwight) Business Overview

Table 99. Vitafusion (Church & Dwight) Circadian Rhythm Sleep Disorders Drug Product

Table 100. Vitafusion (Church & Dwight) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)

Table 101. Vitafusion (Church & Dwight) Recent Development

Table 102. OLLY (Unilever) Company Details

Table 103. OLLY (Unilever) Business Overview

Table 104. OLLY (Unilever) Circadian Rhythm Sleep Disorders Drug Product

Table 105. OLLY (Unilever) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)

Table 106. OLLY (Unilever) Recent Development

Table 107. Doctor's Best (Kingdomway) Company Details

Table 108. Doctor's Best (Kingdomway) Business Overview

Table 109. Doctor's Best (Kingdomway) Circadian Rhythm Sleep Disorders Drug Product

Table 110. Doctor's Best (Kingdomway) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)

Table 111. Doctor's Best (Kingdomway) Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Circadian Rhythm Sleep Disorders Drug Picture

Figure 2. Global Circadian Rhythm Sleep Disorders Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Circadian Rhythm Sleep Disorders Drug Market Share by Type: 2024 VS 2031

Figure 4. Melatonin Features

Figure 5. Ramelteon Features

Figure 6. Others Features

Figure 7. Global Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Circadian Rhythm Sleep Disorders Drug Market Share by Application: 2024 VS 2031

Figure 9. Delayed Sleep Phase Syndrome (DSPS) Case Studies

Figure 10. Advanced Sleep Phase Syndrome (ASPS) Case Studies

Figure 11. Irregular Sleep-Wake Disorder (ISWD) Case Studies

Figure 12. Others Case Studies

Figure 13. Circadian Rhythm Sleep Disorders Drug Report Years Considered

Figure 14. Global Circadian Rhythm Sleep Disorders Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Circadian Rhythm Sleep Disorders Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Circadian Rhythm Sleep Disorders Drug Market Share by Region: 2024 VS 2031

Figure 17. Global Circadian Rhythm Sleep Disorders Drug Market Share by Players in 2024

Figure 18. Global Top Circadian Rhythm Sleep Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circadian Rhythm Sleep Disorders Drug as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Circadian Rhythm Sleep Disorders Drug Revenue in 2024

Figure 20. North America Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Circadian Rhythm Sleep Disorders Drug Market Share by Country (2020-2031)

Figure 22. United States Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Circadian Rhythm Sleep Disorders Drug Market Share by Country (2020-2031)

Figure 26. Germany Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Share by Region (2020-2031)

Figure 34. China Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Circadian Rhythm Sleep Disorders Drug Market Share by Country (2020-2031)

Figure 42. Mexico Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Share by Country (2020-2031)

Figure 46. Turkey Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Teva Pharmaceuticals Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

Figure 50. Takeda Pharmaceutical Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

Figure 51. NBTY Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

Figure 52. Vicks (Procter & Gamble) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

Figure 53. Natrol Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

Figure 54. Nature Made (Pharmavite) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

Figure 55. Jameison Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

Figure 56. GNC Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

Figure 57. By-Health Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

Figure 58. Now Foods Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

Figure 59. Vitafusion (Church & Dwight) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

Figure 60. OLLY (Unilever) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

Figure 61. Doctor's Best (Kingdomway) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Sleep Disorders Treatment Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10Y19260

Wed Mar 12 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Liquid Snore Stopper Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29F12885

Fri Mar 07 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Circadian Rhythm Sleep Disorders Drug Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18T13228

Thu Mar 06 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Noise-isolating Sleeping Earplugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9N19185

Wed Mar 05 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions